A novel ganglioside-bound form of the amyloid β-protein is discovered in Alzheimer's disease (pages 1062–1066), but is it the long-sought initiator of the earliest brain lesions?
References
Suzuki, N. et al. An increased percentage of long amyloid β protein secreted by familial amyloid β protein precursor (βAPP717) mutants. Science 264, 1336–1340 (1994).
Citron, M. et al. Excessive production of amyloid β-protein by peripheral cells of symptomatic and presymptomatic patients carrying the Swedish familial Alzheimer's disease mutation. Proc. natn. Acad. Sci. USA. 91, 11993–11997 (1994).
Haass, C., Hung, A.Y., Selkoe, D.J. & Teplow, D.B. Mutations associated with a locus for familial Alzheimer's disease result in alternative processing of amyloid β-protein precursor. J. biol. Chem. 269, 17741–17748 (1994).
Games, D. et al. Alzheimer-type neuropathology in transgenic mice overexpressing V717F β-amyloid precursor protein. Nature 373, 523–527 (1995).
Schmechel, D.E. et al. Increased amyloid β-pep-tide deposition in cerebral cortex as a consequence of apolipoprotein E genotype in late-onset Alzheimer's disease. Proc. natn. Acad. Sci. U.S.A. 90, 9649–9653 (1993).
Hyman, B.T. et al. Quantitative analysis of senile plaques in Alzheimer's disease: Observation of log-normal size distribution and molecular epidemiology of differences associated with apolipoprotein E genotype and trisomy 21 (Down syndrome). Proc. natn. Acad. Sci. U.S.A. 92, 3586–3590 (1995).
Scheuner, D. et al. Fibroblasts from carriers of familial AD linked to chromosome 14 show increased Aβ production. Soc. Neurosci. Abstr. (in the press).
Querfurth, H.W., Wijsman, E.M., St. George-Hyslop, P.H. & Selkoe, D.J. βAPP mRNA transcription is increased in cultured fibroblasts from the familial Alzheimer's disease-1 family. Molec. Brain Res. 28, 319–337 (1995).
Pike, C.J., Burdick, D., Walencewicz, A.J., Glabe, C.G. & Cotman, C.W. Neurodegeneration induced by beta-amyloid peptides in vitro: The role of peptide assembly state. J. Neurosci. 13, 1676–1687 (1993).
Lorenzo, A. & Yankner, B. β-Amyloid neurotoxicity requires fibril formation and is inhibited by Congo red. Proc. natn. Acad. Sci. U.S.A. 91, 12243–12247 (1994).
Masliah, E. et al. Re-evaluation of the structural organization of neuritic plaques in Alzheimer's disease. J. Neuropath, exp. Neurol. 52, 619–632 (1993).
Yanagisawa, K., Odaka, A., Suzuki, N. & Ihara, Y. GM1 ganglioside-bound amyloid β-protein (Aβ): A possible form of preamyloid in Alzheimer disease. Nature Med. 1, 1062–1066 (1995).
Mori, H., Takio, K., Ogawara, M. & Selkoe, D.J. Mass spectrometry of purified amyloid β protein in Alzheimer's disease. J. biol. Chem. 267, 17082–17086 (1992).
Roher, A.E. et al. Chemical characterization of Aβ 17-42 peptide: A component of diffuse amyloid deposits of Alzheimer disease. J. biol. Chem. 269, 10987–10990 (1994).
Saido, T.C. et al. Dominant and differential deposition of distinct β-amyloid peptide species, AβN3(p3), in senile plaques. Neuron 14, 457–466 (1995).
Gravina, S.A. et al. Amyloid β protein (Aβ) in Alzheimer's disease brain: Biochemical and immunocytochemical analysis with antibodies specific for forms ending at Aβ40 or Aβ42(43). J. biol Chem. 270, 7013–7016 (1995).
Koo, E.H. & Squazzo, S. Evidence that production and release of amyloid β-protein involves the endocytic pathway. J. biol. Chem. 269, 17386–17389 (1994).
Author information
Authors and Affiliations
Rights and permissions
About this article
Cite this article
Selkoe, D. Alzheimer's amyloid of another flavour. Nat Med 1, 998–999 (1995). https://doi.org/10.1038/nm1095-998
Issue Date:
DOI: https://doi.org/10.1038/nm1095-998
- Springer Nature America, Inc.